Record $3 billion disbursed in 2010 by Global Fund to Fight AIDS
The Global Fund to Fight AIDS, Tuberculosis and Malaria disbursed a record $3 billion in 2010. This helped boost the number of people on antiretroviral therapy in Global Fund-supported programs to an estimated 3 million; increase the number of people treated for multidrug resistant TB by half; and contribute to a big expansion in malaria treatment and prevention.
These remarkable results are part of “Making a Difference,” a new report launched on May 19 in Paris which shows in detail how the Global Fund has helped to save 6.5 million lives between 2002 and 2010.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze